Related Experiment Video
Updated: Mar 17, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Knowledge and Attitude Toward Human Papillomavirus (HPV) and Its Vaccination in the Saudi Population: A Systematic
Eman Alshehri1,2, Khalid M Akkour1,2, Ahmed Sherif Abdel Wahab2,3
1Obstetrics and Gynecology Department, Faculty of Medicine, King Saud University, Riyadh, SAU.
Abstract:
Human papillomavirus (HPV) vaccination represents an important public health opportunity in Saudi Arabia. This systematic review aimed to evaluate knowledge, attitudes, and uptake regarding the HPV vaccine among various demographic groups in the country. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive search of databases, including PubMed/MEDLINE, Embase, Web of Science, Scopus, Cochrane Library, and PsycINFO, was conducted from inception through December 2025. The review included studies providing quantitative data on HPV vaccine knowledge, attitudes, beliefs, or uptake. A total of 28 studies published between 2014 and 2024 were analyzed, including studies involving parents, students, and healthcare professionals. Findings revealed a notable prevention paradox: while reported willingness to vaccinate was moderate to high (29.1-87.9%), actual vaccination uptake was consistently low (1-23%). Significant gaps in knowledge were identified, with limited awareness of HPV's association with cervical cancer and optimal vaccination timing. Factors such as higher education and healthcare employment predicted greater acceptance, whereas barriers included safety concerns, insufficient provider engagement, and sociocultural influences. The review concludes that suboptimal HPV vaccine uptake stems largely from systemic and informational gaps. A coordinated national strategy, featuring public education, healthcare provider training, and programmatic interventions such as school-based vaccination, is urgently needed to improve coverage and reduce HPV-related cancer burden.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Sexually Transmitted Infections
Cancer Prevention
Some...